Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.45 |
| ▸ | P4HTM | Q9NXG6 | 3/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | CCR1 | P32246 | 2/20 | 0.44 |
| ▸ | CCR5 | P51681 | 2/20 | 0.44 |
| ▸ | CCR8 | P51685 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | METAP1 | P53582 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7521569 | 0.91 | CES2 (0.48) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL245065 | 0.88 | NPC1 (0.46) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL11865903 | 0.86 | CES2 (0.46) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL28667662 | 0.86 | CES2 (0.39) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL101751 | 0.84 | LMNA (0.48) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL28960343 | 0.84 | CES2 (0.45) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL3676096 | 0.84 | CES2 (0.45) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL8893245 | 0.83 | ELANE (0.45) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL6642658 | 0.83 | TSHR (0.38) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL5081081 | 0.83 | CES2 (0.37) | CES2CES1LMNAL3MBTL1P4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099776-A1 | A PROCESS FOR THE PREPARATION OF PACLITAXEL | FRESENIUS KABI ONCOLOGY LTD. (IN) | 2026-05-15 | — | — | WO | claimed |
| CN-119852517-A | Sodium ion battery electrolyte | 中石油深圳新能源研究院有限公司 | 2025-04-18 | — | — | CN | claimed |
| EP-3645492-B1 | PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS | UNIV LEUVEN KATH (BE) | 2024-08-21 | — | — | EP | claimed |
| CN-110809570-B | Preparation method of ortho-alkoxy bisphenol monomer | 鲁汶天主教大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115515644-A | Antibody-drug conjugate, preparation method and application thereof | 昆山新蕴达生物科技有限公司 | 2022-12-23 | — | — | CN | claimed |
| US-11414519-B2 | Ortho alkoxy bisphenol monomers | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2022-08-16 | — | — | US | claimed |
| CN-109988296-B | Process for producing polycarbonate polyol and polycarbonate polyol composition | 财团法人工业技术研究院 | 2021-09-10 | — | — | CN | claimed |
| CN-111082139-B | Non-aqueous electrolyte and lithium ion battery | 东莞东阳光科研发有限公司 | 2020-10-09 | — | — | CN | claimed |
| US-10689488-B2 | Method for preparing polycarbonate polyol and composition comprising the polycarbonate polyol | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-06-23 | — | — | US | claimed |
| EP-3645492-A1 | PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS | Katholieke Universiteit Leuven (BE) | 2020-05-06 | — | — | EP | claimed |
| EP-0666857-A1 | METHOD FOR PREPARING TAXANE DERIVATIVES | Aventis Pharma S.A. (FR) | 1995-08-16 | — | — | EP | claimed |
| WO-1994018186-A1 | SYNTHESIS OF TAXOL, ANALOGS AND INTERMEDIATES WITH VARIABLE A-RING SIDE CHAINS | BRYN MAWR COLLEGE (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0599973-A1 | PROCESS FOR THE PREPARATION OF BETA-PHENYLISOSERINE DERIVATIVES AND USE THEREOF | Aventis Pharma S.A. (FR) | 1994-06-08 | — | — | EP | claimed |
| WO-1994010169-A1 | METHOD FOR PREPARING TAXANE DERIVATIVES | RHONE-POULENC RORER S.A. (FR) | 1994-05-11 | — | — | WO | claimed |
| US-RE34277-E | Process for preparing taxol | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1993-06-08 | — | — | US | claimed |
| WO-1993004038-A1 | PROCESS FOR THE PREPARATION OF BETA-PHENYLISOSERINE DERIVATIVES AND USE THEREOF | RHONE-POULENC RORER S.A. (FR) | 1993-03-04 | — | — | WO | claimed |
| EP-0528729-A1 | Process for the preparation of beta-phenylisoserine derivatives and their utilisation | Aventis Pharma S.A. (FR) | 1993-02-24 | — | — | EP | claimed |
| US-4924011-A | CONDENSATION, ESTERIFICATION; ANTITUMOR AND ANITLEUKEMIA AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1990-05-08 | — | — | US | claimed |
| US-4924012-A | Process for preparing derivatives of baccatine III and of 10-deacetyl baccatine III | RHONE-POULENC SANTE (FR) | 1990-05-08 | — | — | US | claimed |
| EP-0253738-B1 | TAXOL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC SANTE (FR) | 1990-01-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11414519-B2 | Ortho alkoxy bisphenol monomers | ALK, ESR1, ADIPOR1 | CES2 385/4885CES1 73/4885LMNA 2642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.